6 key updates on Aurora Spine’s 1st trache of non-brokered private placement

Aurora Spine completed the first trache of common share non-brokered private placement.

Advertisement

Here are six things to know:

 

1. The company issued 2.3 million common shares at CDN $1.25 per share.

 

2. The aggregate gross proceeds are expected to reach CDN $2.9 million.

 

3. Aurora Spine is planning more traches of the offering on a rolling basis, hoping to amass CDN $4 million in total gross proceeds.

 

4. Aurora Spine paid CDN $109,600 in finders’ fees in connection with the offering to certain arm’s length finders. This amount is equal to 8 percent of the proceeds raised under the tranche offering.

 

5. Net proceeds will be used for general working capital purposes.

 

6. Director of Aurora Spine David Rosenkrantz directly or indirectly subscribed for 160,000 common shares under the initial tranche offering.

 

More articles on spine devices:
LDR, Amendia, Precision Spine & more—18 key notes
MIS instruments market: 7 key trends
DJO’s net loss down to $90.5M in 2014—10 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.